Mi-thos® Transcatheter Mitral Valve Replacement Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 122 participants.

Also called NCT04195984

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 122 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04195984
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT04195984. Allocation not applicable; no masking; primary purpose treatment. Start 2021-03-25 (actual); primary completion 2026-05 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Mi-thos® Transcatheter Mitral Valve Replacement Study
Condition
Mitral Valve Regurgitation
Intervention (Device)
Mi-thos® valve and transapical delivery system
Lead sponsor
Shanghai NewMed Medical Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct04195984
Content hash
3e5be69260bb813298dc4edee7f747e51851703cef9591fee51c458b938e28a8